|  |
 |
 |
 |
 |
| Cloning-Derived Stem Cells Raise Policy Questionsby Jessica Cussins, Biopolitical TimesMay 16th, 2013Yesterday’s announcement that stem cells have been derived from cloned human embryos set off a media flurry, but important questions about reproductive cloning and women’s health were not widely addressed. |
| Talking Biopolitics is Back!by Jessica Cussins, Biopolitical TimesMay 13th, 2013A series of live web-based conversations with cutting-edge thinkers on the social meaning of human biotechnologies will be kicking off next week. RSVP now to join the conversations!
|
| Made-to-Order Embryos: You Want to Sell What?!by Jessica Cussins, Biopolitical TimesMay 2nd, 2013The fact that a fertility clinic can own and sell made-to-order embryos for profit raises novel concerns that should not be collapsed into predefined frameworks used to assess other assisted reproductive technologies.
|
| Earth Day in Biopoliticsby Jessica Cussins, Biopolitical TimesApril 22nd, 2013In honor of Earth Day, let’s hope for a move away from “greenwashed” PR stunts and techno-fixes toward conservation, sustainability, and social responsibility. |
| Shifts in the Global Body Market: Access or Exploitation?by Jessica Cussins, Biopolitical TimesApril 1st, 2013PlanetHospital claims that new surrogacy regulations in India have ruined a “golden opportunity” and paints Mexico and Thailand as the surrogacy frontiers – where it happens to have business arrangements.
|
| Experiments with Inheritable Genetic Modificationby Jessica Cussins, Biopolitical TimesMarch 13th, 2013A developmental biologist looks carefully at research on mitochondria replacement that would be an experimental form of human inheritable genetic modification. |
| GM Babies?by Jessica Cussins, Biopolitical TimesMarch 5th, 2013A debate about genetically engineered babies is hijacked by slick rhetoric.
|
|
|
 |
 |
 |
 |
|  |
|